Search

Search Results

• 

  Adherence to cervical cancer screening in an Italian SLE cohort

  C. Tani, L. Carli, M. Mosca, C. Baldini, A. Consensi, M. Doveri, R. Talarico, S. Bombardieri

  11-17

  Published:

  1218

  PDF: 747

• Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience

  L. Cometi, P. Francesconi, B. Bellini, L. Turco, F. Voller, F. Nacci, S. Bellando-Randone, M. Matucci-Cerinic, S. Guiducci

  22-03-2024

  Published: 22 March 2024

  597

  PDF: 347

• BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity

  M. Vadacca, D. Margiotta, D. Sambataro, F. Buzzulini, M. Lo Vullo, A. Rigon, A. Afeltra

  259-265

  Published:

  1792

  PDF: 1978
• 

  Anti-N-methyl-d-aspartate receptor encephalitis: mimicker of lupus and multiple sclerosis

  N. Sanghavi, B. Ayesha

  19-12-2023

  Published: 19 December 2023

  1092

  PDF: 286

• The main stages in the history of systemic lupus erythematosus

  M. Rampudda, P. Marson, G. Pasero

  145-152

  Published:

  1830

  PDF: 1748

• Systemic lupus erythematosus: the first italian prevalence study

  M. Benucci, F. Li Gobbi, A. Del Rosso, M. Manfredi

  103-108

  Published:

  1208

  PDF: 1343
• 

  Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome

  V. Bruzzese, P. Scolieri, J. Pepe

  07-02-2022

  Published: 7 February 2022

  5580

  PDF: 564

• Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR+CD25- cell subset in patients with systemic lupus erythematosus

  A. Alunno, G. Nocentini, O. Bistoni, R. Bianchini, E. Bartoloni Bocci, C. Riccardi, R. Gerli

  195-201

  Published:

  1213

  PDF: 812
• 

  Jaccoud’s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment

  M. Benucci, A. Damiani, F. Li Gobbi, V. Grossi, M. Infantino, A. Arena, M. Manfredi

  88-91

  03-08-2017

  Published: 3 August 2017

  1845

  PDF: 915

• Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?

  L. Andreoli, F. Pregnolato, R.W. Burlingame, V. Fanelli, F. Allegri, A. Radice, C. Corace, R.A. Sinico, A. Tinconi, P.L. Meroni

  185-191

  Published:

  1074

  PDF: 1046

• Sensibility and specificity for pregnancy morbidity of anti-b2-glycoprotein I antibodies in antiphospholipid syndrome

  M. Tonello, A. Ruffatti, M. Favaro, T. Del Ross, D. Zamboni, P. Grypiotis, A. Cavazzana, M. Ciprian, S. Todesco

  262-266

  Published:

  1051

  PDF: 1003
• 

  Diagnostic and prognostic role of renal histopathology in rheumatic diseases

  F. Saccon, M. Gatto, M. Larosa, F. Ometto, M. Felicetti, R. Padoan, M. Zen

  165-177

  03-10-2018

  Published: 3 October 2018

  2072

  PDF: 1480

• Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

  S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi

  107-112

  Published:

  1181

  PDF: 678

• Central nervous system involvement in patients with HCV-related cryoglobulinemia: review and a case report

  D. Filippini, F. Colombo, S. Jann, R. Corneo, B. Canesi

  150-155

  Published:

  1329

  PDF: 1693

• Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD

  C. Tani, M. Mosca, A. d'Ascanio, D. Versari, A. Virdis, L. Ghiadoni, S. Taddei, A. Salvetti, S. Bombardieri

  212-218

  Published:

  1706

  PDF: 1277
• 

  Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus

  B. Joob, V. Wiwanitkit

  171

  24-10-2019

  Published: 24 October 2019

  1219

  PDF: 695

• Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases

  C. Sales, F. Oliviero, P. Spinella

  95-101

  Published:

  2467

  PDF: 1730
• 

  Serum KL-6 as predictive and prognostic marker of interstitial lung disease in childhood connective tissue diseases: a pilot study

  R. El-Beheidy, A.M. Domouky, H. Zidan, Y.A. Amer

  22-11-2021

  Published: 22 November 2021

  6408

  PDF: 877

• Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations

  A. Tincani, C. Casu, S. Cartella, T. Ziglioli, R. Cattaneo

  65-75

  Published:

  1687

  PDF: 3090

• Thalidomide in treatment of connective diseases and vasculities

  N. Maruotti, F.P. Cantatore, D. Ribatti

  187-190

  Published:

  1330

  PDF: 1064

• Possible role of Hsp70 in autoantigens shuttling to dermo-epidermal junction in systemic lupus erythematosus

  R. Villalobos-Hurtado, S.H. Sánchez-Rogriguez, E. Avalos-Díaz, R. Herrera-Esparza

  155-158

  Published:

  765

  PDF: 800

• Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

  M.G. Portuesi, P. Perosa

  61-63

  Published:

  1118

  PDF: 843
• 

  A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools

  S. Pirri, R. Talarico, D. Marinello, G. Turchetti, M. Mosca

  22-11-2021

  Published: 22 November 2021

  6157

  PDF: 664

• Isolated congenital heart block in undifferentiated connective tissue disease and in primary Sjögren’s syndrome: a clinical study of 81 pregnancies in 41 patients

  C. Grava, A. Ruffatti, O. Milanesi, M. Favaro, M. Tonello, A. Calligaro, T. Del Ross, S. Todesco

  180-186

  11-04-2005

  Published: 11 April 2005

  1188

  PDF: 3950

• Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients

  S. Cuffaro, T. Del Ross, M. Tonello, A. Bontadi, S. Olivieri, E. Salvan, A. Ruffatti, L. Punzi

  51-59

  Published:

  1347

  PDF: 737

• Multiple Sclerosis and autoimmune diseases: clinical cases and review of the literature

  G. Castellino, A. Protti, B. Canesi

  196-203

  Published:

  905

  PDF: 5155
• 

  Kikuchi-Fujimoto disease with multiple extra-nodal features - A clinical mimic

  C.A. Mansoor, Z. Shemin

  105-107

  09-07-2019

  Published: 9 July 2019

  1254

  PDF: 841

• Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis

  M. Vadacca, R. Bruni, F. Caccipaglia, F. Serino, L. Arcarese, F. Buzzulini, G. Coppolino, A. Rigon, N. Terminio, A. Afeltra

  50-56

  Published:

  1828

  PDF: 1038

• Pulmonary hypertension in autoimmune rheumatic diseases

  B. Marasini, M. Massarotti, R. Cossutta, L. Massironi, A. Mantero

  114-118

  Published:

  833

  PDF: 2687

• Malar rash in a painting by Jean-Baptiste Siméon Chardin (1699-1779)

  P. Marson, R. Rondinone, M. Vicarioto

  175-179

  Published:

  1213

  PDF: 802

• Metabolic syndrome in inflammatory rheumatic diseases

  D. Malesci, G. Valentini, G. La Montagna

  169-176

  Published:

  1603

  PDF: 3801
• 

  Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis

  D.J. Manzella, L. Vicente, A.A. Pérez de la Hoz, R.J. Zamora, G. De Rosa, A.A. Pisarevsky

  92-98

  09-07-2019

  Published: 9 July 2019

  1228

  PDF: 932

• Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting

  A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari

  324-330

  Published:

  815

  PDF: 2645

• Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”

  M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri

  35-40

  Published:

  1718

  PDF: 1457

• Quality of life in systemic lupus erythematosus

  S. Rinaldi, A. Doria, F. Vescovi, S. Corbanese, L. Iaccarino, S. Della Libera, G. Perini, P.F. Gambari

  108-115

  Published:

  1405

  PDF: 1222

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  Published:

  1648

  PDF: 1654

• Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide

  C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri

  215-220

  Published:

  1138

  PDF: 773

• A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies

  R. Gutiérrez-Ramos, V. González-Díaz, M.G. Pacheco-Tovar, A. López-Luna, E. Avalos-Díaz, R. Herrera-Esparza

  296-300

  Published:

  2026

  PDF: 1052

• Recombinant adenovirus-mediated gene transfer suppresses experimental arthritis

  E. Quattrocchi, M. Feldmann

  46-54

  Published:

  648

  PDF: 687

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  Published:

  818

  PDF: 1953
• 

  Histopathology of the skin in rheumatic diseases

  M.S. Chimenti, A. Di Stefani, P. Conigliaro, A. Saggini, S. Urbani, A. Giunta, M. Esposito, L. Bianchi, K. Peris, R. Perricone

  187-198

  03-10-2018

  Published: 3 October 2018

  2662

  PDF: 1712

• Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

  P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco

  232-237

  Published:

  1518

  PDF: 5879

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  Published:

  1078

  PDF: 720
• 

  Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran

  R. Assari, P. Sadeghi, A. Mirmohammadsadeghi, F. Ebadi, V. Ziaee

  189-198

  28-01-2020

  Published: 28 January 2020

  1559

  PDF: 876

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  Published:

  1382

  PDF: 1007

• Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  Published: 25 September 2024

  479

  PDF: 96